These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 36099330)
1. Triphosphate Prodrugs of the Anti-HIV-Active Compound 3'-Deoxy-3'-fluorothymidine (FLT). Weising S; Weber S; Schols D; Meier C J Med Chem; 2022 Sep; 65(18):12163-12175. PubMed ID: 36099330 [TBL] [Abstract][Full Text] [Related]
2. Partial selective inhibition of HIV-1 reverse transcriptase and human DNA polymerases γ and β by thiated 3'-fluorothymidine analogue 5'-triphosphates. Wińska P; Miazga A; Poznański J; Kulikowski T Antiviral Res; 2010 Nov; 88(2):176-81. PubMed ID: 20739003 [TBL] [Abstract][Full Text] [Related]
3. Prodrugs of γ-Alkyl-Modified Nucleoside Triphosphates: Improved Inhibition of HIV Reverse Transcriptase. Zhao C; Weber S; Schols D; Balzarini J; Meier C Angew Chem Int Ed Engl; 2020 Dec; 59(49):22063-22071. PubMed ID: 32379948 [TBL] [Abstract][Full Text] [Related]
4. Balancing antiviral potency and host toxicity: identifying a nucleotide inhibitor with an optimal kinetic phenotype for HIV-1 reverse transcriptase. Sohl CD; Kasiviswanathan R; Kim J; Pradere U; Schinazi RF; Copeland WC; Mitsuya H; Baba M; Anderson KS Mol Pharmacol; 2012 Jul; 82(1):125-33. PubMed ID: 22513406 [TBL] [Abstract][Full Text] [Related]
5. Lipophilic Nucleoside Triphosphate Prodrugs of Anti-HIV Active Nucleoside Analogs as Potential Antiviral Compounds. Jia X; Schols D; Meier C Adv Sci (Weinh); 2023 Dec; 10(36):e2306021. PubMed ID: 37884485 [TBL] [Abstract][Full Text] [Related]
6. Perspectives on the molecular mechanism of inhibition and toxicity of nucleoside analogs that target HIV-1 reverse transcriptase. Anderson KS Biochim Biophys Acta; 2002 Jul; 1587(2-3):296-9. PubMed ID: 12084471 [TBL] [Abstract][Full Text] [Related]
7. Membrane Permeable, Bioreversibly Modified Prodrugs of Nucleoside Diphosphate-γ-Phosphonates. Jia X; Weber S; Schols D; Meier C J Med Chem; 2020 Oct; 63(20):11990-12007. PubMed ID: 32991174 [TBL] [Abstract][Full Text] [Related]
8. γ-Ketobenzyl-Modified Nucleoside Triphosphate Prodrugs as Potential Antivirals. Nack T; Dinis de Oliveira T; Weber S; Schols D; Balzarini J; Meier C J Med Chem; 2020 Nov; 63(22):13745-13761. PubMed ID: 33186038 [TBL] [Abstract][Full Text] [Related]
9. Highly selective action of triphosphate metabolite of 4'-ethynyl D4T: a novel anti-HIV compound against HIV-1 RT. Yang G; Dutschman GE; Wang CJ; Tanaka H; Baba M; Anderson KS; Cheng YC Antiviral Res; 2007 Mar; 73(3):185-91. PubMed ID: 17109975 [TBL] [Abstract][Full Text] [Related]
11. A 4'-C-ethynyl-2',3'-dideoxynucleoside analogue highlights the role of the 3'-OH in anti-HIV active 4'-C-ethynyl-2'-deoxy nucleosides. Siddiqui MA; Hughes SH; Boyer PL; Mitsuya H; Van QN; George C; Sarafinanos SG; Marquez VE J Med Chem; 2004 Oct; 47(21):5041-8. PubMed ID: 15456247 [TBL] [Abstract][Full Text] [Related]
12. Anti-human immunodeficiency virus type 1 activity, intracellular metabolism, and pharmacokinetic evaluation of 2'-deoxy-3'-oxa-4'-thiocytidine. de Muys JM; Gourdeau H; Nguyen-Ba N; Taylor DL; Ahmed PS; Mansour T; Locas C; Richard N; Wainberg MA; Rando RF Antimicrob Agents Chemother; 1999 Aug; 43(8):1835-44. PubMed ID: 10428900 [TBL] [Abstract][Full Text] [Related]
14. Lipophilic Triphosphate Prodrugs of Various Nucleoside Analogues. Jia X; Schols D; Meier C J Med Chem; 2020 Jul; 63(13):6991-7007. PubMed ID: 32515595 [TBL] [Abstract][Full Text] [Related]
15. Membrane-permeable Triphosphate Prodrugs of Nucleoside Analogues. Gollnest T; Dinis de Oliveira T; Rath A; Hauber I; Schols D; Balzarini J; Meier C Angew Chem Int Ed Engl; 2016 Apr; 55(17):5255-8. PubMed ID: 27008042 [TBL] [Abstract][Full Text] [Related]
16. Anti-HIV type 1 activity of 3'-fluoro-3'-deoxythymidine for several different multidrug-resistant mutants. Kim EY; Vrang L; Oberg B; Merigan TC AIDS Res Hum Retroviruses; 2001 Mar; 17(5):401-7. PubMed ID: 11282008 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of 1-beta-D-2,6-diaminopurine dioxolane, a prodrug of the human immunodeficiency virus type 1 inhibitor 1-beta-D-dioxolane guanosine. Furman PA; Jeffrey J; Kiefer LL; Feng JY; Anderson KS; Borroto-Esoda K; Hill E; Copeland WC; Chu CK; Sommadossi JP; Liberman I; Schinazi RF; Painter GR Antimicrob Agents Chemother; 2001 Jan; 45(1):158-65. PubMed ID: 11120959 [TBL] [Abstract][Full Text] [Related]
18. 5-Chloro-2',3'-dideoxy-3'-fluorouridine (935U83), a selective anti-human immunodeficiency virus agent with an improved metabolic and toxicological profile. Daluge SM; Purifoy DJ; Savina PM; St Clair MH; Parry NR; Dev IK; Novak P; Ayers KM; Reardon JE; Roberts GB Antimicrob Agents Chemother; 1994 Jul; 38(7):1590-603. PubMed ID: 7526782 [TBL] [Abstract][Full Text] [Related]
19. In vitro anti-hepatitis B virus activities of 5"-O-myristoyl analogue derivatives of 3"-fluoro-2",3"-dideoxythymidine (FLT) and 3"-azido-2",3"-dideoxythymidine (AZT). Parang K; Wiebe LI; Knaus EE; Huang JS; Tyrrell DL J Pharm Pharm Sci; 1998; 1(3):108-14. PubMed ID: 10948398 [TBL] [Abstract][Full Text] [Related]
20. Effects of beta-L-3'-azido-3'-deoxythymidine 5'-triphosphate on host and viral DNA polymerases. Faraj A; El Alaoui AM; Gosselin G; Imbach JL; Morrow C; Sommadossi JP Antiviral Res; 2000 Aug; 47(2):97-102. PubMed ID: 10996397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]